Association of Interleukin-10 Polymorphism (rs1800896, rs1800871, and rs1800872) with Breast Cancer Risk: an Updated Meta-Analysis Based on Different Ethnic Groups
Abstract Background: There have been various publications stating that IL-10 gene polymorphism is connected with the risk of breast cancer.This study was to further evaluate the association between IL-10 gene polymorphism and breast cancer (BC).Methods: Articles from PubMed, Web of Knowledge, Embase, CNKI databases, China biomedical (CBM), and Google Scholar before March 29, 2020. The data was analyzed by Revman5.3 and Stata 12.0 software, and the strength of the association was identified using the odds ratio (OR) and the corresponding 95% confidence interval (CI).Results: A total of 23 studies (7250 cancer cases and 7675 case-free controls) were eligible for the mate-analysis. The results show that IL-10 gene polymorphisms has no association with BC risk in any genetic model of the general population. However, there is significantly correlated with BC risk based on subgroup analysis by ethnicity: rs1800896 polymorphism are significantly associated with the risk of BC in Asian population based on the four models (G vs. A: OR= 0.78, 95% CI=0.65-0.95, P= 0.01; GG vs. AA: OR=0.51, 95% CI=0.31-0.84, P=0.007; GA vs. AA: OR=0.6, 95% CI=0.44-0.81, P=0.0009; GG+GA vs. AA: OR=0.6, 95% CI=0.45-0.81, P= 0.0007); rs1800871 polymorphism has association with BC risk in Caucasian population based on the Heterozygous model (CT vs. TT: OR=1.8, 95% CI =1.03-3.13, P=0.04). rs1800872 homozygous model was associated with the BC risk in Asians(AA vs CC: OR=0.74, 95%CI =0.55-0.99, P =0.04), and allelic model was associated with BC risk among Asians (A vs C: OR= 0.85, 95% CI =0.74-0.98, P= 0.03) and among Caucasians (A vs C: OR= 0.65, 95% CI 0.43-0.98, P =0.04). Conclusion: IL-10 gene polymorphism rs1800896 and rs1800872 significantly increased the risk of breast cancer in Asians, while rs1800871 was associated with the risk of breast cancer in Caucasians. Therefore, vulnerable individuals can be identified by genotypic characteristics, and the diseases can be prevented through interventions aimed at high-risk groups.